A detailed history of Perceptive Advisors LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 2,362,279 shares of CELC stock, worth $29.4 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares
2,362,279
Previous 2,362,279 -0.0%
Holding current value
$29.4 Million
Previous $38.7 Million 8.98%
% of portfolio
0.92%
Previous 1.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.74 - $21.6 $12.1 Million - $19 Million
880,979 Added 59.47%
2,362,279 $51 Million
Q4 2023

Feb 14, 2024

BUY
$8.7 - $15.02 $12.9 Million - $22.2 Million
1,481,300 New
1,481,300 $21.6 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $186M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.